Andrew Guggenhime - Net Worth and Insider Trading

Andrew Guggenhime Net Worth

The estimated net worth of Andrew Guggenhime is at least $6 Million dollars as of 2024-04-29. Andrew Guggenhime is the PRESIDENT AND CFO of Vaxcyte Inc and owns about 95,679 shares of Vaxcyte Inc (PCVX) stock worth over $6 Million. Andrew Guggenhime is also the COO and CFO of Dermira Inc and owns about 5,116 shares of Dermira Inc (DERM) stock worth over $95,925. Details can be seen in Andrew Guggenhime's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Andrew Guggenhime has not made any transactions after 2024-04-18 and currently still holds the listed stock(s).

Transaction Summary of Andrew Guggenhime

To

Andrew Guggenhime Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Andrew Guggenhime owns 5 companies in total, including Metacrine Inc (MTCR) , Vaxcyte Inc (PCVX) , and Dermira Inc (DERM) among others .

Click here to see the complete history of Andrew Guggenhime’s form 4 insider trades.

Insider Ownership Summary of Andrew Guggenhime

Ticker Comapny Transaction Date Type of Owner
MTCR Metacrine Inc 2020-09-15 director
PCVX Vaxcyte Inc 2024-04-18 CFO & CBO
DERM Dermira Inc 2020-02-20 CFO
PDLI PDL BioPharma Inc 2008-12-18 SVP & Chief Financial Officer
CRBU Caribou Biosciences Inc 2021-07-22 director

Andrew Guggenhime Latest Holdings Summary

Andrew Guggenhime currently owns a total of 2 stocks. Among these stocks, Andrew Guggenhime owns 95,679 shares of Vaxcyte Inc (PCVX) as of April 18, 2024, with a value of $6 Million and a weighting of 98.39%. Andrew Guggenhime also owns 5,116 shares of Dermira Inc (DERM) as of November 9, 2016, with a value of $95,925 and a weighting of 1.61%.

Latest Holdings of Andrew Guggenhime

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PCVX Vaxcyte Inc 2024-04-18 95,679 61.25 5,860,339
DERM Dermira Inc 2016-11-09 5,116 18.75 95,925

Holding Weightings of Andrew Guggenhime


Andrew Guggenhime Form 4 Trading Tracker

According to the SEC Form 4 filings, Andrew Guggenhime has made a total of 18 transactions in Vaxcyte Inc (PCVX) over the past 5 years, including 0 buys and 18 sells. The most-recent trade in Vaxcyte Inc is the sale of 8,000 shares on April 18, 2024, which brought Andrew Guggenhime around $490,160.

According to the SEC Form 4 filings, Andrew Guggenhime has made a total of 0 transactions in Dermira Inc (DERM) over the past 5 years. The most-recent trade in Dermira Inc is the sale of 4,100 shares on November 9, 2016, which brought Andrew Guggenhime around $143,582.

Insider Trading History of Andrew Guggenhime

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Andrew Guggenhime Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Andrew Guggenhime Ownership Network

Ownership Network List of Andrew Guggenhime

No Data

Ownership Network Relation of Andrew Guggenhime


Andrew Guggenhime Owned Company Details

What does Metacrine Inc do?

Who are the key executives at Metacrine Inc?

Andrew Guggenhime is the director of Metacrine Inc. Other key executives at Metacrine Inc include Chief Business Officer Michael York , director & President & CEO Preston Klassen , and 10 percent owner Braden Michael Leonard .

Metacrine Inc (MTCR) Insider Trades Summary

Over the past 18 months, Andrew Guggenhime made no insider transaction in Metacrine Inc (MTCR). Other recent insider transactions involving Metacrine Inc (MTCR) include a net purchase of 435,875 shares made by Braden Michael Leonard , a net sale of 380,605 shares made by Preston Klassen , and a net sale of 107,054 shares made by Michael York .

In summary, during the past 3 months, insiders sold 0 shares of Metacrine Inc (MTCR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 487,659 shares of Metacrine Inc (MTCR) were sold and 435,875 shares were bought by its insiders, resulting in a net sale of 51,784 shares.

Metacrine Inc (MTCR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Metacrine Inc Insider Transactions

No Available Data

Andrew Guggenhime Mailing Address

Above is the net worth, insider trading, and ownership report for Andrew Guggenhime. You might contact Andrew Guggenhime via mailing address: C/o Vaxcyte, Inc., 825 Industrial Road, Ste. 300, San Carlos Ca 94070.

Discussions on Andrew Guggenhime

No discussions yet.